These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37890649)

  • 21. Early-onset neonatal group B streptococcal sepsis: intrapartum antibiotic prophylaxis in the clinical setting.
    Gervasio CT; Mantaring BS; Alankar S; Shankaran S
    J Perinatol; 2001; 21(1):9-14. PubMed ID: 11268874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrapartum antibiotics and early onset neonatal sepsis caused by group B Streptococcus and by other organisms in Australia. Australasian Study Group for Neonatal Infections.
    Isaacs D; Royle JA
    Pediatr Infect Dis J; 1999 Jun; 18(6):524-8. PubMed ID: 10391182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial prevention of early-onset group B streptococcal sepsis: estimates of risk reduction based on a critical literature review.
    Benitz WE; Gould JB; Druzin ML
    Pediatrics; 1999 Jun; 103(6):e78. PubMed ID: 10353975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic choice for Group B Streptococcus prophylaxis in mothers with reported penicillin allergy and associated newborn outcomes.
    Snider JB; Mithal LB; Kwah JH; Rhodes NJ; Son M
    BMC Pregnancy Childbirth; 2023 May; 23(1):400. PubMed ID: 37254067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duration of intrapartum antibiotics for group B streptococcus on the diagnosis of clinical neonatal sepsis.
    Turrentine MA; Greisinger AJ; Brown KS; Wehmanen OA; Mouzoon ME
    Infect Dis Obstet Gynecol; 2013; 2013():525878. PubMed ID: 23606801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review.
    Benitz WE; Gould JB; Druzin ML
    Pediatrics; 1999 Jun; 103(6):e77. PubMed ID: 10353974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevalence and adverse effects of group B streptococcal colonization during pregnancy.
    Namavar Jahromi B; Poorarian S; Poorbarfehee S
    Arch Iran Med; 2008 Nov; 11(6):654-7. PubMed ID: 18976037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for group B streptococcus early-onset disease: an Italian, area-based, case-control study.
    Berardi A; Spada C; Creti R; Ambretti S; Chiarabini R; Barozzi A; Pagano R; Sarti M; Pedna MF; Fornaciari S; Azzalli M; Dodi I; Bacchi Reggiani ML; Lanzoni A; Vaccina E; Iughetti L; Lucaccioni L
    J Matern Fetal Neonatal Med; 2020 Jul; 33(14):2480-2486. PubMed ID: 31170843
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of intrapartum antibiotic prophylaxis for the prevention of early-onset group B streptococcal infection.
    Sakata H
    J Infect Chemother; 2012 Dec; 18(6):853-7. PubMed ID: 22614121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Group B Streptococcal infection in neonates and colonization in pregnant women: An epidemiological retrospective analysis.
    Cho CY; Tang YH; Chen YH; Wang SY; Yang YH; Wang TH; Yeh CC; Wu KG; Jeng MJ
    J Microbiol Immunol Infect; 2019 Apr; 52(2):265-272. PubMed ID: 28882582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exposure to group B Streptococcal antibiotic prophylaxis and early childhood body mass index in a vaginal birth cohort.
    Metz TD; McKinney J; Allshouse AA; Knierim SD; Carey JC; Heyborne KD
    J Matern Fetal Neonatal Med; 2020 Oct; 33(19):3318-3323. PubMed ID: 30651010
    [No Abstract]   [Full Text] [Related]  

  • 32. Prenatal screening for group B Streptococcus. I. Impact of antepartum screening on antenatal prophylaxis and intrapartum care.
    Mercer BM; Ramsey RD; Sibai BM
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):837-41. PubMed ID: 7573254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Characteristics of group b streptococcus vertical transmission].
    Andreu Domingo A; Salcedo Abizanda S; Heredia Prim F; González Morlans J; Bartolomé Comas RM; Cabero Roura L
    An Esp Pediatr; 1997 Apr; 46(4):383-8. PubMed ID: 9214233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The risk factors for Group B Streptococcus colonization during pregnancy and influences of intrapartum antibiotic prophylaxis on maternal and neonatal outcomes.
    Chen X; Cao S; Fu X; Ni Y; Huang B; Wu J; Chen L; Huang S; Cao J; Yu W; Ye H
    BMC Pregnancy Childbirth; 2023 Mar; 23(1):207. PubMed ID: 36973793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of a screening program for the prevention of neonatal early-onset group B Streptococcus infection: a population-based cohort study in Inner Mongolia, China.
    Ji Y; Zhao C; Ma XX; Peppelenbosch MP; Ma Z; Pan Q
    J Med Microbiol; 2019 May; 68(5):803-811. PubMed ID: 30994439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease.
    Lin FY; Brenner RA; Johnson YR; Azimi PH; Philips JB; Regan JA; Clark P; Weisman LE; Rhoads GG; Kong F; Clemens JD
    Am J Obstet Gynecol; 2001 May; 184(6):1204-10. PubMed ID: 11349189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrapartum antibiotic prophylaxis for Group B Streptococcus: has the time come to wait more than 4 hours?
    Turrentine M
    Am J Obstet Gynecol; 2014 Jul; 211(1):15-7. PubMed ID: 24315859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine.
    Schrag SJ; Verani JR
    Vaccine; 2013 Aug; 31 Suppl 4():D20-6. PubMed ID: 23219695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventing early-onset group B streptococcal sepsis: is there a role for rescreening near term?
    Mirsky R; Carpenter DM; Postlethwaite DA; Regenstein AC
    J Matern Fetal Neonatal Med; 2020 Nov; 33(22):3791-3797. PubMed ID: 30890002
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevalence and treatment of group B streptococcus colonization based on risk factors versus intrapartum culture screening.
    Johansen NR; Kjærbye-Thygesen A; Jønsson S; Westh H; Nilas L; Rørbye C
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():178-181. PubMed ID: 31301553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.